Skip to main content
Clinical Trials/NCT03794895
NCT03794895
Completed
Not Applicable

Assessment of Efficacy of Uterine Artery Doppler in Predicting the Response to Mefenamic Acid During Treatment of Women With IUCD Associated Menorrhagia

Ain Shams University1 site in 1 country156 target enrollmentMay 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Women's Health: Amenorrhea/Dysmenorrhea
Sponsor
Ain Shams University
Enrollment
156
Locations
1
Primary Endpoint
Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia

Registry
clinicaltrials.gov
Start Date
May 1, 2017
End Date
May 1, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yasmine Essam Eldin Mohamed Mohamed Ismail

Principal investigator

Ain Shams University

Eligibility Criteria

Inclusion Criteria

  • women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion

Exclusion Criteria

  • history of bleeding tendency
  • history of abnormal uterine bleeding due to other causes
  • history of active liver disease
  • history of antiplatelet or anticoagulant intake in the last month
  • history of thyroid disease
  • history of endometritis
  • history of allergy to NSAIDs
  • Adenomyosis
  • women having contraindications to use NSAIDs e.g. peptic ulcer
  • Insulin dependant diabetes mellitus

Outcomes

Primary Outcomes

Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia)

Time Frame: 1 year

Base line uterine artery doppler is done to the patient complaining of IUCD related menorrhagia prior to treatment , parameters of doppler are: resistance index and pulsitality index, then the patient takes mefenamic acid tablets 500 mg three times daily for five days, assessment of response whether the patient is responder or not is done using pictorial blood loss assessment chart then base line doppler parameters in responders and non responders are compared to correlate the response to base line doppler parameters

Study Sites (1)

Loading locations...

Similar Trials